Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BridgeBio Pharma, Inc. | Director | Common Stock | 12K | $420K | $35.00 | Apr 14, 2025 | Direct |
BridgeBio Pharma, Inc. | Director | Stock Option (right to buy) | 64.9K | Apr 14, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Apr 14, 2025 | 3 | -$266K | 4 | Apr 16, 2025 | Director |
BBIO | BridgeBio Pharma, Inc. | Apr 1, 2025 | 3 | -$768K | 4 | Apr 3, 2025 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Mar 15, 2022 | 1 | $101K | 4 | Mar 17, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 26, 2021 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 17, 2021 | 0 | $0 | 3 | Aug 26, 2021 | Director |